Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000083769 | SCV000629044 | benign | Familial Mediterranean fever | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000593418 | SCV000709301 | benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000756331 | SCV000884108 | likely benign | not provided | 2017-07-26 | criteria provided, single submitter | clinical testing | The MEFV c.333G>A;p.Gly111Gly variant has not been described in the medical literature, but is listed in a gene-specific database in a symptomatic individual (see link). The variant is listed in the ClinVar database (Variation ID: 97517) and the dbSNP variant database (rs61732425) with an allele frequency of up to 0.7373 percent (32/4308 alleles) in the African American population in the Exome Variant Server and up to 1.081 percent in the African population in the Genome Aggregation Consortium (251/23226 alleles, 2 homozygotes). The nucleotide at this position is weakly conserved and computational algorithms (SpliceSiteFinder-like, MaxEntScan, NNSplice, GeneSplicer, Human Splicing Finder) predict this variant does not significantly alter splicing. Considering available information, this variant is classified as likely benign. References: Link to Infevers database: http://fmf.igh.cnrs.fr/ISSAID/infevers/search.php?n=1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000593418 | SCV001426904 | likely benign | not specified | 2020-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000756331 | SCV001891062 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262645 | SCV002543755 | likely benign | Autoinflammatory syndrome | 2020-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321582 | SCV002605620 | likely benign | Inborn genetic diseases | 2022-04-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000083769 | SCV003802413 | likely benign | Familial Mediterranean fever | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003126473 | SCV003802414 | benign | Familial Mediterranean fever, autosomal dominant | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003126474 | SCV003802415 | benign | Acute febrile neutrophilic dermatosis | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Unité médicale des maladies autoinflammatoires, |
RCV000083769 | SCV000115865 | not provided | Familial Mediterranean fever | no assertion provided | not provided | ||
Natera, |
RCV000083769 | SCV002087469 | likely benign | Familial Mediterranean fever | 2019-12-09 | no assertion criteria provided | clinical testing |